Inspire Medical Systems, Inc. (INSP) Stock Score, Valuation & Financial Research
Inspire Medical Systems, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 67/100.
Quick answer for INSP
Inspire Medical Systems, Inc. currently has a Wall Street Score of 67/100. The stored market price is $73.55. Its financial score is 27/100. Its valuation score is 97/100. The latest WSS change is -2.6 points. These figures are a research snapshot, not a buy or sell recommendation.
What Inspire Medical Systems, Inc. does
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
INSP financial snapshot
- Wall Street Score:
- 67/100
- Current price:
- $73.55
- Market capitalization:
- $2.13B
- Revenue:
- $898.7M
- Net income:
- $135.0M
- Free cash flow:
- $78.5M
- Cash:
- $127.8M
- Total debt:
- $29.1M
- EPS:
- 4.95
- P/E ratio:
- 14.9x
- Financial score:
- 27/100
- Valuation score:
- 97/100
- Revenue score:
- 36/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $78.5M, showing positive cash generation.
- The balance sheet shows $127.8M of cash versus $29.1M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is -2.6 points: INSP decreased 2.6 points because Revenue declined by 2 points, Asset declined by 2.2 points, Capital declined by 5 points.
What the numbers mean
Its current valuation score is 97/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 27/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research INSP
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.